Our hypothesis is further supported by the evidence that either chemical and ischemic preconditioning was shown to attenuate ischemia-induced mRNA elevations of inflammatory cytokines (i.e., IL-1β and IL-6), while not affecting the elevation of the protective TGF-β occurring in the ischemic cortex (66). The gene discussed is TGFB1; the disease is ischemia.